RTW Investments, LP 13D and 13G filings for Akero Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:00 am Purchase |
2024-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
RTW Investments, LP | 6,859,823 9.800% |
940,388 (+15.89%) |
Filing |
| 2024-11-14 06:51 am Purchase |
2024-09-30 | 13G | Akero Therapeutics, Inc. AKRO |
RTW Investments, LP | 5,919,435 8.500% |
2,326,676 (+64.76%) |
Filing |
| 2024-02-14 07:06 am Purchase |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
RTW Investments, LP | 3,592,759 6.400% |
3,592,759 (New Position) |
Filing |